Paper41379378
Vav1 Sustains the Expression of Insulin, PDX1 and miR-375 During Differentiation of hiPSCs to β Cells: A Potential Target to Improve the In Vitro Generation of Insulin-Producing Cells.
Pierantoni M and 7 others. Tissue Eng Regen Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Vav1 Sustains the Expression of Insulin, PDX1 and miR-375 During Differentiation of hiPSCs to β Cells: A Potential Target to Improve the In Vitro Generation of Insulin-Producing Cells. Papers, record 41379378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41379378
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vav1 Sustains the Expression of Insulin, PDX1 and miR-375 During Differentiation of hiPSCs to β Cells: A Potential Target to Improve the In Vitro Generation of Insulin-Producing Cells.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proto-Oncogene Proteins c-vav | Major topic |
| MicroRNAs | Major topic |
| Trans-Activators | Major topic |
| Insulin-Secreting Cells | Major topic |
| Insulin | Major topic |
| Induced Pluripotent Stem Cells | Major topic |
| Homeodomain Proteins | Major topic |
| Cell Differentiation | Major topic |
| Humans |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FIRD 2022 | Università degli Studi di Ferrara | PubMed | ||
| FIRD 2023 | Università degli Studi di Ferrara | PubMed | ||
| Hub Life Science - Terapia Avanzata (LSH--TA) PNC-E3-2022-23683269 - CUP: C43C22002210001 | Ministero della Salute | PubMed |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30251567 | Differentiation of Sendai Virus-Reprogrammed iPSC into β Cells, Compared with Human Pancreatic Islets and Immortalized β Cell Line. | Cell Transplant | 2018 | https://conductscience.org/library/papers/30251567 | PubMed |
| 2 | 39301900 | Association between Higher Expression of Vav1 in Hepatocellular Carcinoma and Unfavourable Clinicopathological Features and Prognosis. | Protein Pept Lett | 2024 | https://conductscience.org/library/papers/39301900 | PubMed |
| 3 | 36113507 | Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. | Lancet Diabetes Endocrinol | 2022 | https://conductscience.org/library/papers/36113507 | PubMed |
| 4 | 39060140 | VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases. | Trends Immunol | 2024 | https://conductscience.org/library/papers/39060140 | PubMed |
| 5 | 19833727 | Glucose regulates steady-state levels of PDX1 via the reciprocal actions of GSK3 and AKT kinases. | J Biol Chem | 2010 | https://conductscience.org/library/papers/19833727 | PubMed |
| 6 | 24962430 | High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process. | Oncotarget | 2014 | https://conductscience.org/library/papers/24962430 | PubMed |
| 7 | 37545183 | Vav1-dependent Rac1 activation mediates hypoxia-induced gemcitabine resistance in pancreatic ductal adenocarcinoma cells through upregulation of HIF-1α expression. | Cell Biol Int | 2023 | https://conductscience.org/library/papers/37545183 | PubMed |
| 8 | 19541499 | Akt and PTEN: beta-cell mass and pancreas plasticity. | Trends Endocrinol Metab | 2009 | https://conductscience.org/library/papers/19541499 | PubMed |
| 9 | 29532991 | Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/29532991 | PubMed |
| 10 | 21821793 | Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21821793 | PubMed |
| 11 | 40116625 | Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future. | Biomol Biomed | 2025 | https://conductscience.org/library/papers/40116625 | PubMed |
| 12 | 38786044 | Effects of Garlic on Breast Tumor Cells with a Triple Negative Phenotype: Peculiar Subtype-Dependent Down-Modulation of Akt Signaling. | Cells | 2024 | https://conductscience.org/library/papers/38786044 | PubMed |
| 13 | 26318486 | Specific and redundant roles of PKBα/AKT1 and PKBβ/AKT2 in human pancreatic islets. | Exp Cell Res | 2015 | https://conductscience.org/library/papers/26318486 | PubMed |
| 14 | 34571765 | VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/34571765 | PubMed |
| 15 | 35743776 | Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype. | J Pers Med | 2022 | https://conductscience.org/library/papers/35743776 | PubMed |
| 16 | 33246884 | Transcriptional dynamics of induced pluripotent stem cell differentiation into β cells reveals full endodermal commitment and homology with human islets. | Cytotherapy | 2021 | https://conductscience.org/library/papers/33246884 | PubMed |
| 17 | 17158802 | Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/17158802 | PubMed |
| 18 | 39929222 | Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy. | Lancet Diabetes Endocrinol | 2025 | https://conductscience.org/library/papers/39929222 | PubMed |
| 19 | 40124184 | The future of islet transplantation beyond the BLA approval: challenges and opportunities. | Front Transplant | 2025 | https://conductscience.org/library/papers/40124184 | PubMed |
| 20 | 21856460 | Nuclear proteome analysis reveals a role of Vav1 in modulating RNA processing during maturation of tumoral promyelocytes. | J Proteomics | 2011 | https://conductscience.org/library/papers/21856460 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42626274 | SLC30A8 (ZnT8) at the crossroads of epigenetics and microRNA regulation in type 2 diabetes and nephropathy. | World J Nephrol | 2026 | https://conductscience.org/library/papers/42626274 |
Source PubMed
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| MIR375 | 494324 | PubTator's text mining | https://conductscience.org/library/genes/494324 | NCBI Gene |
| PDX1 | 3651 | PubTator's text mining | https://conductscience.org/library/genes/3651 | NCBI Gene |
| VAV1 | 7409 | PubTator's text mining | https://conductscience.org/library/genes/7409 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41379378
GET https://conductscience.org/api/papers/v1/41379378/references?page=2